PHASE-II STUDIES OF 2 TRIAL REGIMENS OF TOPOTECAN AS 2ND-LINE SINGLE-AGENT THERAPY IN ADVANCED BREAST-CANCER

Citation
D. Spaeth et al., PHASE-II STUDIES OF 2 TRIAL REGIMENS OF TOPOTECAN AS 2ND-LINE SINGLE-AGENT THERAPY IN ADVANCED BREAST-CANCER, European journal of cancer, 33, 1997, pp. 704-704
Citations number
NO
Categorie Soggetti
Oncology
Journal title
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
8
Pages
704 - 704
Database
ISI
SICI code
0959-8049(1997)33:<704:PSO2TR>2.0.ZU;2-8